Cargando…

Lipids in Chronic Obstructive Pulmonary Disease: A Target for Future Therapy?

Detalles Bibliográficos
Autor principal:	Vlahos, Ross
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Thoracic Society 2020
Materias:	Editorials
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7055703/ https://www.ncbi.nlm.nih.gov/pubmed/31577908 http://dx.doi.org/10.1165/rcmb.2019-0338ED

Ejemplares similares

Role of Alveolar Macrophages in Chronic Obstructive Pulmonary Disease
por: Vlahos, Ross, et al.
Publicado: (2014)

Chronic Obstructive Pulmonary Disease: The Present and Future
por: Krishnan, Aditya, et al.
Publicado: (2022)

Transcriptome-based Signatures: The Future Biomarkers in Obstructive Pulmonary Diseases Such as Asthma and Chronic Obstructive Pulmonary Disease?
por: van den Berge, Maarten, et al.
Publicado: (2021)

New frontiers in the treatment of comorbid cardiovascular disease in chronic obstructive pulmonary disease
por: Brassington, Kurt, et al.
Publicado: (2019)

Chronic obstructive pulmonary disease and atherosclerosis: common mechanisms and novel therapeutics
por: Brassington, Kurt, et al.
Publicado: (2022)

Bronchiectasis as a Comorbidity of Chronic Obstructive Pulmonary Disease: Implications and Future Research
por: Chen, Ya-Hong, et al.
Publicado: (2016)

Glucocorticoid insensitivity as a future target of therapy for chronic obstructive pulmonary disease
por: Marwick, John A, et al.
Publicado: (2010)

Classical and Emerging Therapies against Chronic Obstructive Pulmonary Disease
por: Feng, Han-Rong, et al.
Publicado: (2018)

MicroRNA Control Lipid-laden Alveolar Macrophages in Smokers: A Potential Therapeutic Target for Chronic Obstructive Pulmonary Disease?
por: Massara, Layal, et al.
Publicado: (2022)

The future of inhalation therapy in chronic obstructive pulmonary disease
por: Cazzola, Mario, et al.
Publicado: (2022)

Chronic Obstructive Pulmonary Disease in Super-Aged Society: A Letter From the Near Future
por: Hwang, Hun-Gyu
Publicado: (2023)

Is One Exacerbation Enough to Modify Therapy in Chronic Obstructive Pulmonary Disease?
por: Mannino, David M.
Publicado: (2023)

What is the contribution of respiratory viruses and lung proteases to airway remodelling in asthma and chronic obstructive pulmonary disease?
por: Gualano, Rosa C., et al.
Publicado: (2006)

Allergy and Chronic Obstructive Pulmonary Disease
por: Jin, Jian-Min, et al.
Publicado: (2017)

Inhaled Antibiotics and Airway Bacterial Decolonization for Patients with Chronic Obstructive Pulmonary Disease: The Rationale and Future
por: Han, Yaopin, et al.
Publicado: (2022)

Calming Nervous Airways: Targeted Lung Denervation for Chronic Obstructive Pulmonary Disease
por: Aaron, Shawn D., et al.
Publicado: (2019)

Addressing the Use of the CAPTURE (a Chronic Obstructive Pulmonary Disease Screening Tool) in Chronic Obstructive Pulmonary Disease Treatment Decisions
por: Yawn, Barbara P., et al.
Publicado: (2023)

More attention to comprehensive assessment and individualized therapy of chronic obstructive pulmonary disease
por: Hou, Gang, et al.
Publicado: (2015)

Triple therapy in chronic obstructive pulmonary disease: consideration under new evidence
por: Gao, Yong-Hua, et al.
Publicado: (2021)

The Complex Beginnings of Chronic Obstructive Pulmonary Disease
por: Guerra, Stefano, et al.
Publicado: (2020)

Smoking cessation and chronic obstructive pulmonary disease
por: Yoo, Kwang Ha
Publicado: (2015)

Metabolic syndrome and chronic obstructive pulmonary disease
por: Koul, Parvaiz A
Publicado: (2016)

Diaphragmatic dysfunction in chronic obstructive pulmonary disease
por: Sharma, Bharat Bhushan, et al.
Publicado: (2019)

Macrolides for treatment of chronic obstructive pulmonary disease
por: Sun, Xue-Jiao, et al.
Publicado: (2019)

Interpretation of the Key Issues of Expert Consensus on Immunomodulatory Therapies for Chronic Obstructive Pulmonary Disease
por: Sun, Lina, et al.
Publicado: (2023)

Lipid metabolism in chronic obstructive pulmonary disease
por: Chen, Haipin, et al.
Publicado: (2019)

Targeted therapy in eosinophilic chronic obstructive pulmonary disease
por: Fieldes, Mathieu, et al.
Publicado: (2021)

Pathobiological mechanisms underlying metabolic syndrome (MetS) in chronic obstructive pulmonary disease (COPD): clinical significance and therapeutic strategies
por: Chan, Stanley M.H., et al.
Publicado: (2019)

What Affects Chronic Obstructive Pulmonary Disease in Korea?
por: Cho, Hae-Wol, et al.
Publicado: (2016)

High prevalence of chronic obstructive pulmonary disease in Korea
por: Rhee, Chin Kook
Publicado: (2016)

Drugging the Mighty Neutrophil in Chronic Obstructive Pulmonary Disease
por: Fessler, Michael B.
Publicado: (2019)

Validation of Imaging Measures in Chronic Obstructive Pulmonary Disease
por: Aaron, Carrie Pistenmaa, et al.
Publicado: (2019)

Chronic Obstructive Pulmonary Disease and Work: Is It Time to Stop?
por: Halpin, David
Publicado: (2019)

Genetics, Chronic Obstructive Pulmonary Disease, and the Arrow of Time
por: Calverley, Peter M. A., et al.
Publicado: (2019)

The Saga of Necroptosis in Chronic Obstructive Pulmonary Disease Continues
por: Racanelli, Alexandra C., et al.
Publicado: (2021)

The Paradox of Obesity in Patients with Chronic Obstructive Pulmonary Disease
por: Yohannes, Abebaw Mengistu
Publicado: (2022)

The role of quantitative imaging in chronic obstructive pulmonary disease
por: Wada, Danilo Tadao
Publicado: (2022)

Fixed Triple Therapy in Chronic Obstructive Pulmonary Disease and Survival. Living Better, Longer, or Both?
por: Vestbo, Jørgen
Publicado: (2020)

Pulse Oximetry Misclassifies Need for Long-Term Oxygen Therapy in Chronic Obstructive Pulmonary Disease
por: Fawzy, Ashraf, et al.
Publicado: (2023)

Mind the Gap: Addressing Cardiovascular Disease in Chronic Obstructive Pulmonary Disease
por: Wells, J. Michael, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_bge7qo28gi8pp9tt3vkpia5h36